Answers are grounded in this paper and cite their sources.
Review highlights combined use of orthobiologics and hydrogels to improve outcomes in osteoarthritis, suggesting innovative therapies.
Osteoarthritis is a significant global problem, causing pain and limitations, and contributing to socioeconomic expenses. The etiopathogenesis of this disease encloses genetic, biological, and mechanical aspects. Regenerative medicine, utilizing tissue engineering, has opened the way to new therapeutic approaches employing various orthobiologics. Combined with hydrogels, these compounds may represent a notable option for treating degenerative and inflammatory lesions in OA. The review reports on the main orthobiologics used in preclinical and clinical studies, as well as their association with various types of natural and synthetic hydrogels. Research may increasingly focus on tailored therapies adjusted to suit the joint involved and the severity of the pathology encountered in each patient.
No takes yet. Share an insight, caveat, or question.
Cavallo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: